Alpine Immune Sciences Inc reports results for the quarter ended in March - Earnings Summary

Alpine Immune Sciences

11/05/2023 23:00

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 28 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 37 cents per share.
    * Revenue fell 31.1% to $9.39 million from a year ago;
analysts
expected $8.60 million. 
    * Alpine Immune Sciences Inc's reported EPS for the quarter
was a
loss of 28 cents​.
    * The mean earnings estimate of analysts had fallen by
about 18.3%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Alpine Immune Sciences Inc shares had risen by 1.9% this
quarter and gained 7.1% so far this year.
    * The company reported a quarterly loss of $13.27 million.
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $16.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 10:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.37          -0.28          Beat
 Dec. 31 2022      -0.27          -0.41          Missed
 Sep. 30 2022      -0.10          -0.42          Missed
 Jun. 30 2022      -0.39          -0.60          Missed